Phase 3 Trial Results of Stelara for Crohn’s Disease Indicate Promising Results

Phase 3 Trial Results of Stelara for Crohn’s Disease Indicate Promising Results
Janssen Pharmaceuticals’ drug candidate Stelara (ustekinumab) demonstrated positive therapeutic effects in a recent Phase 3 clinical trial, inducing clinical response and remission in adult patients with moderate to severe Crohn’s disease who had been treated with anti-tumor necrosis factor (TNF)-alpha therapy and were either unresponsive or intolerant to it. The efficacy and safety results from the

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

3 comments

  1. Ma Fletcher says:

    Stelara – nasty side effects – headaches in morning in bed
    – pain in right testicle
    – cramp in right leg every morning
    – slowing down my Crohn’s diarrhoea a lot but it’s not worth the side effects

    • Sharon Mooney says:

      I Had my first infusion on Tuesday, been feeling as if im coming down with a cold or feel Fluey! and my Joints ache as well, im hoping this will settle down soon. Haven’t had any feed back from my Consultant as myself and another patient of his are the first ones in my area to go on this new treatment!! so im reading what I can online…… how long will this last for, and for how long??? Any Advice from fellow patients.x

Leave a Comment

Your email address will not be published. Required fields are marked *